AthleticsMD Clinical DeskSchedule an evaluation
In the news · GLP-1 and weight-loss drugs

Austin father loses vision after taking Wegovy; questions raised about rare condition

Headline from yahoo.com

KXAN reports on Jason Horek, a south Austin father who lost much of the vision in his right eye from NAION, a rare optic nerve condition, months after starting Wegovy. A May American Academy of Ophthalmology review of 40 studies found semaglutide may be associated with about a twofold increase in relative risk, but ophthalmology groups say causation has not been proven and more research is needed.

Why it matters: Relevant to Maryland adults using or considering semaglutide for medical weight loss, and to the clinicians who prescribe it or evaluate sudden vision changes.

Read the full story at yahoo.com →

A summary of another publisher's reporting, written with AI and checked automatically against the story. The reporting belongs to yahoo.com. October 5, 2026.

AthleticsMD Clinical Desk

Today's front page

The newest articles and the day's news on GLP-1 & weight loss, Metabolic health, Hormones and more.

Go to the front page →